- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
短期的强势行情可能结束，投资者及时短线卖出、离场观望为宜。
- 中期趋势：
已发现中线买入信号。
- 长期趋势：
已有18家主力机构披露2026-06-30报告期持股数据，持仓量总计2535.27万股，占流通A股1.64%
- 波段诊断：
-
技术面诊股
诊断结果：8.1技术面打败了99%的股票
技术面评分前10的股票
近期的平均成本为17.61元。空头行情中，目前正处于反弹阶段，投资者可适当关注。已发现中线买入信号。
平均成本
近期的平均成本为17.61元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"17.61","date":1784622585,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑赢大盘，明显跑赢行业平均水平。
[{"date":"2026.07.22","stock":"0.69","trade":"0.08","ind":"0.07"},{"date":"2026.07.21","stock":"-1.02","trade":"-1.41","ind":"1.79"},{"date":"2026.07.20","stock":"1.38","trade":"-0.39","ind":"0.85"},{"date":"2026.07.17","stock":"-2.24","trade":"-7.15","ind":"-3.05"},{"date":"2026.07.16","stock":"0.85","trade":"0.97","ind":"-1.85"},{"date":"2026.07.15","stock":"0.63","trade":"3.85","ind":"-0.29"},{"date":"2026.07.14","stock":"1.21","trade":"2.69","ind":"1.36"},{"date":"2026.07.13","stock":"0.29","trade":"-0.42","ind":"-2.06"},{"date":"2026.07.10","stock":"0.41","trade":"3.20","ind":"-1.00"},{"date":"2026.07.09","stock":"0.76","trade":"-0.42","ind":"1.65"},{"date":"2026.07.08","stock":"-0.87","trade":"-1.44","ind":"-0.49"},{"date":"2026.07.07","stock":"-1.82","trade":"-4.17","ind":"-1.26"},{"date":"2026.07.06","stock":"-0.96","trade":"0.97","ind":"-0.06"},{"date":"2026.07.03","stock":"3.19","trade":"1.73","ind":"0.37"},{"date":"2026.07.02","stock":"2.93","trade":"1.10","ind":"-2.03"},{"date":"2026.07.01","stock":"1.76","trade":"5.64","ind":"0.44"},{"date":"2026.06.30","stock":"-2.14","trade":"-1.27","ind":"0.50"},{"date":"2026.06.29","stock":"2.63","trade":"5.87","ind":"1.16"},{"date":"2026.06.26","stock":"-1.50","trade":"-4.86","ind":"-2.26"},{"date":"2026.06.25","stock":"-2.41","trade":"-1.35","ind":"0.23"},{"date":"2026.06.24","stock":"-0.76","trade":"-0.89","ind":"0.11"}]
ST人福,上证指数,化学制药指数
压力支撑
该股压力位为17.57元，支撑位为17.41元。
[{"text":"\u538b\u529b\u4f4d","value":"17.57","date":1784649600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"17.41","date":1784649600,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前正处于反弹阶段，投资者可适当关注。已发现中线买入信号。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：1.9资金面打败了6%的股票
主力控盘前10的股票
行业资金
化学制药行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：07月22日 17:18
| 机构今日流向(万元) | -1011.84 | 机构5日流向(万元) | -4548.61 |
| 机构10日流向(万元) | -381.26 | 机构20日流向(万元) | -975.85 |
机构持仓
2026-06-30 与 2025-12-31 相比，主力机构持仓量减少59078.05万股，其中基金净减仓3家，主力净减仓171家，请投资者中长期谨慎为宜。
截止2026-06-30，共18家主力机构（基金18家），持仓量总计2535.27万股，占流通A股1.64%
其中，基金持仓与2025-12-31相比：
增仓：5家 ，增持 134.04万股
减仓：8家 ，减持 458.08万股
新出现在主力名单中：0家 ，持有万股
从主力名单中消失：171家 ，原持有58754.01万股
其中，基金持仓与2025-12-31相比：
增仓：5家 ，增持 134.04万股
减仓：8家 ，减持 458.08万股
新出现在主力名单中：0家 ，持有万股
从主力名单中消失：171家 ，原持有58754.01万股
消息面诊股
诊断结果：6.3消息面打败了81%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 【准入】28个国谈药拟进院，独家品种“疯涨”
2026-07-20 - 【市场】人福医药抢攻贴膏剂首仿
2026-07-17 - 行业周报|化学制药指数跌-0.45%, 跑赢上证指
2026-07-17 - 【市场】人福医药1类新药来袭，抢攻300亿市场
2026-07-13 - ST人福：尼达尼布软胶囊获得美国FDA批准文号
2026-07-10 - 变卖生产基地、转让非核心资产，药企接连“出招”下的
2026-07-09 - ST人福：HW211026软膏进入II期临床试验研
2026-07-09 - ST人福：盐酸氢吗啡酮片获药物临床试验批准
2026-07-06 - 涉超150股！A股交易规则重大调整，主板风险警示股
2026-07-06 - 涨跌幅限制放宽背后：影响百只个股，为何切忌“博一博
2026-07-02
消息列表
| 一般消息 | 重大事项 | 关联交易 | 2026-06-19 |
| 一般消息 | 重大事项 | 关联交易 | 2026-06-06 |
| 一般消息 | 股东大会 | 临时股东大会 | 2026-06-05 |
| 一般消息 | 募资投向 | 公司出售资产 | 2026-06-05 |
| 利好 | 分红转增 | 10派4.80元(含税) | 2026-03-31 |
| 一般消息 | 高管变动 | 个人原因 | 2026-02-24 |
| 一般消息 | 重大事项 | 关联交易 | 2026-01-31 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-12-31 |
| 利空 | 重大事项 | 公司违规：处罚类型 | 2025-12-30 |
| 利空 | 重大事项 | 公司违规：处罚类型 | 2025-12-29 |
| 利空 | 上市变动 | 特别处理ST | 2025-12-16 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-11-08 |
| 一般消息 | 重大事项 | 关联交易 | 2025-10-14 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-28 |
| 一般消息 | 资产重组 | 公司股权转让 | 2025-08-01 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-07-30 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 2条 | 0条 | 2条 |
| 利空 | 3条 | 0条 | 3条 |
行业面诊股
诊断结果：7.0行业面打败了94%的股票
化学制药行业最新资金流向
近10日来该行业走势不明显，跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，跑赢大盘。
[{"date":"2026.07.22","price":"0.07","value":"0.08"},{"date":"2026.07.21","price":"1.79","value":"-1.41"},{"date":"2026.07.20","price":"0.85","value":"-0.39"},{"date":"2026.07.17","price":"-3.05","value":"-7.15"},{"date":"2026.07.16","price":"-1.85","value":"0.97"},{"date":"2026.07.15","price":"-0.29","value":"3.85"},{"date":"2026.07.14","price":"1.36","value":"2.69"},{"date":"2026.07.13","price":"-2.06","value":"-0.42"},{"date":"2026.07.10","price":"-1.00","value":"3.20"},{"date":"2026.07.09","price":"1.65","value":"-0.42"},{"date":"2026.07.08","price":"-0.49","value":"-1.44"},{"date":"2026.07.07","price":"-1.26","value":"-4.17"},{"date":"2026.07.06","price":"-0.06","value":"0.97"},{"date":"2026.07.03","price":"0.37","value":"1.73"},{"date":"2026.07.02","price":"-2.03","value":"1.10"},{"date":"2026.07.01","price":"0.44","value":"5.64"},{"date":"2026.06.30","price":"0.50","value":"-1.27"},{"date":"2026.06.29","price":"1.16","value":"5.87"},{"date":"2026.06.26","price":"-2.26","value":"-4.86"},{"date":"2026.06.25","price":"0.23","value":"-1.35"},{"date":"2026.06.24","price":"0.11","value":"-0.89"}]
上证指数,化学制药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 哈药股份 | 91.67% | 33.18% | 5.6分 |
| 2 | - | 75.06% | 5.27% | 分 |
| 3 | 迪哲医药 | 52.88% | -9.97% | 5.0分 |
| 4 | 石药创新 | 52.67% | -5.38% | 5.8分 |
| 5 | 益方生物 | 46.90% | 1.03% | 5.5分 |
| 6 | 泽璟制药 | 40.59% | 5.48% | 6.3分 |
| 8 | 百利天恒 | 33.62% | -0.78% | 5.7分 |
| 10 | 赛分科技 | 32.57% | 12.77% | 6.0分 |
| 12 | - | 26.08% | -6.92% | 分 |
| 14 | 罗欣药业 | 22.89% | 0.61% | 6.6分 |
| 16 | 海正药业 | 22.71% | 4.17% | 6.2分 |
| 18 | 舒泰神 | 18.25% | -4.53% | 5.3分 |
| 20 | 微芯生物 | 16.85% | -6.39% | 5.4分 |
| 22 | 宣泰医药 | 16.09% | -6.38% | 5.5分 |
| 24 | 美诺华 | 15.76% | -25.05% | 5.6分 |
| 26 | 首药控股 | 14.38% | -13.21% | 4.2分 |
| 28 | 京新药业 | 13.76% | -7.64% | 5.6分 |
| 30 | - | 12.86% | -5.79% | 分 |
| 32 | 必贝特 | 11.30% | 0.47% | 5.6分 |
| 34 | 健友股份 | 10.53% | -1.50% | 5.7分 |
| 36 | 信立泰 | 9.55% | -10.97% | 5.4分 |
| 38 | 博瑞医药 | 9.10% | 12.02% | 5.1分 |
| 40 | 华东医药 | 9.03% | -2.00% | 5.9分 |
| 42 | 健康元 | 7.60% | -0.38% | 6.1分 |
| 44 | 华北制药 | 7.13% | -3.22% | 5.6分 |
| 46 | 誉衡药业 | 6.79% | -9.87% | 5.2分 |
| 48 | 金石亚药 | 6.35% | -16.56% | 4.6分 |
| 50 | 浙江医药 | 5.81% | -2.55% | 6.0分 |
| 52 | 东北制药 | 5.19% | -2.92% | 5.8分 |
| 54 | 九典制药 | 5.03% | -2.95% | 5.2分 |
| 56 | 一品红 | 4.53% | -12.02% | 5.0分 |
| 58 | 海创药业 | 4.48% | -6.69% | 4.3分 |
| 60 | 润都股份 | 4.23% | -12.36% | 5.5分 |
| 62 | 海普瑞 | 3.55% | -4.75% | 6.1分 |
| 64 | 石药景峰 | 3.47% | -16.53% | 4.5分 |
| 66 | 泰恩康 | 3.04% | -7.70% | 5.1分 |
| 68 | 贝达药业 | 3.00% | -9.58% | 6.0分 |
| 70 | 千红制药 | 2.61% | -7.48% | 5.1分 |
| 72 | 兴齐眼药 | 2.41% | -6.33% | 5.5分 |
| 74 | 亿帆医药 | 2.01% | -3.15% | 5.8分 |
| 76 | 卫信康 | 1.91% | -8.39% | 4.9分 |
| 78 | 川宁生物 | 1.77% | -1.71% | 5.8分 |
| 80 | 鲁抗医药 | 1.25% | -0.82% | 5.8分 |
| 82 | 神奇制药 | 0.64% | -7.24% | 6.2分 |
| 84 | 华纳药厂 | 0.57% | -18.81% | 4.4分 |
| 86 | 东诚药业 | 0.24% | -5.25% | 5.8分 |
| 88 | 奥锐特 | 0.00% | -6.52% | 5.0分 |
| 90 | 新和成 | -0.49% | 5.48% | 6.4分 |
| 92 | 天宇股份 | -0.76% | -4.93% | 6.0分 |
| 94 | - | -0.83% | -9.53% | 分 |
| 96 | 山河药辅 | -1.49% | -6.72% | 5.1分 |
| 98 | 翰宇药业 | -1.92% | -15.00% | 4.7分 |
| 100 | ST天圣 | -2.11% | -6.63% | 4.3分 |
| 102 | 金城医药 | -2.19% | -10.20% | 5.1分 |
| 104 | 小方制药 | -2.38% | -9.25% | 4.7分 |
| 106 | 华特达因 | -2.66% | -2.10% | 5.9分 |
| 108 | 吉贝尔 | -3.25% | -10.29% | 4.7分 |
| 110 | 海翔药业 | -3.49% | -5.50% | 5.0分 |
| 112 | ST诺泰 | -3.82% | -7.52% | 4.3分 |
| 114 | 双鹭药业 | -4.15% | -16.92% | 4.3分 |
| 116 | ST惠程 | -4.44% | -7.28% | 4.5分 |
| 118 | 悦康药业 | -4.50% | -11.61% | 4.5分 |
| 120 | 圣诺生物 | -4.88% | -19.65% | 4.9分 |
| 122 | 灵康药业 | -5.05% | -32.80% | 5.6分 |
| 124 | 冀衡医药 | -5.48% | -9.64% | 4.8分 |
| 126 | 赛托生物 | -5.90% | -11.36% | 5.1分 |
| 128 | - | -7.84% | -11.05% | 分 |
| 130 | 诚意药业 | -8.08% | -9.73% | 4.7分 |
| 132 | 北陆药业 | -8.36% | -12.09% | 4.9分 |
| 134 | 中哲精化 | -8.76% | -7.92% | 5.2分 |
| 136 | 海森药业 | -9.67% | -10.17% | 4.3分 |
| 138 | 本立科技 | -10.01% | -9.09% | 4.3分 |
| 140 | 昂利康 | -12.43% | -13.86% | 4.5分 |
| 142 | 西点药业 | -12.76% | -13.73% | 5.0分 |
| 144 | 仟源医药 | -13.70% | -16.33% | 4.7分 |
| 146 | 多瑞医药 | -16.41% | -12.49% | 3.8分 |
| 148 | - | -17.29% | -10.88% | 分 |
| 150 | 海辰药业 | -21.61% | -8.81% | 5.2分 |
| 152 | 纳微科技 | -24.14% | -9.32% | 5.5分 |
| 154 | 科源制药 | -25.75% | -30.83% | 4.4分 |
| 156 | 通化金马 | -34.19% | -7.17% | 5.2分 |
| 158 | 宏源药业 | -37.98% | -16.37% | 4.7分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 安信证券 | 2012-09-04 | 增持 | 增持 |
| 长江证券 | 2012-09-02 | 增持 | - |
更多>>行业资讯
- 2012-09-13北京药监局通知全市停用8家企业中药饮片
- 2012-09-13澳洲股指周四收跌0.5% 医疗及消费股领跌
- 2012-09-13基层中医药服务能力将获提升
- 2012-09-132012中国医疗卫生产业发展论坛召开
- 2012-09-13医药行业：媒体称新版基药目录品种将扩至700个
- 2012-09-13陕西县级公立医院改革全面推开
- 2012-09-138月中山CPI 环比涨0.1%
- 2012-09-13中金公司：医药板块选股坚持“稳健业绩+成长空间预期
- 2012-09-13澳洲股指周四盘初跌0.5% 医疗及消费股领跌
- 2012-09-13感冒药“实名制”个人信息易“走光”？ 法国立法严管
基本面诊股
[ 截止日期：2026-03-31 ]公司经营
盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 32/216 ， 78/216。
[{"date":"2026-03-31","value":"3.07","vol":"0.45"},{"date":"2025-12-31","value":"10.16","vol":"-1.85"},{"date":"2025-09-30","value":"9.24","vol":"1.60"},{"date":"2025-06-30","value":"6.42","vol":"1.26"},{"date":"2025-03-31","value":"3.02","vol":"-0.13"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
3.07 | 10.16 | 9.24 | 6.42 | 3.02 |
| 行业(%) | 0.45 | -1.85 | 1.60 | 1.26 | -0.13 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"49.53","vol":"50.98"},{"date":"2025-12-31","value":"48.21","vol":"49.96"},{"date":"2025-09-30","value":"47.95","vol":"49.79"},{"date":"2025-06-30","value":"48.18","vol":"49.69"},{"date":"2025-03-31","value":"48.56","vol":"49.05"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
49.53 | 48.21 | 47.95 | 48.18 | 48.56 |
| 行业(%) | 50.98 | 49.96 | 49.79 | 49.69 | 49.05 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 79/216 ， 63/216。
[{"date":"2026-03-31","value":"-0.59","vol":"24.44"},{"date":"2025-12-31","value":"-5.79","vol":"38.58"},{"date":"2025-09-30","value":"-6.58","vol":"142.64"},{"date":"2025-06-30","value":"-6.20","vol":"79.18"},{"date":"2025-03-31","value":"-3.61","vol":"0.16"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-0.59 | -5.79 | -6.58 | -6.20 | -3.61 |
| 行业(%) | 24.44 | 38.58 | 142.64 | 79.18 | 0.16 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"8.85","vol":"52.58"},{"date":"2025-12-31","value":"39.53","vol":"-24.51"},{"date":"2025-09-30","value":"6.22","vol":"3.72"},{"date":"2025-06-30","value":"3.92","vol":"66.32"},{"date":"2025-03-31","value":"11.09","vol":"-9.37"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
8.85 | 39.53 | 6.22 | 3.92 | 11.09 |
| 行业(%) | 52.58 | -24.51 | 3.72 | 66.32 | -9.37 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 21/216 ， 29/216。
[{"date":"2026-03-31","value":"0.16","vol":"0.10"},{"date":"2025-12-31","value":"0.65","vol":"0.41"},{"date":"2025-09-30","value":"0.49","vol":"0.31"},{"date":"2025-06-30","value":"0.33","vol":"0.21"},{"date":"2025-03-31","value":"0.17","vol":"0.10"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.16 | 0.65 | 0.49 | 0.33 | 0.17 |
| 行业(次) | 0.10 | 0.41 | 0.31 | 0.21 | 0.10 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.91","vol":"0.64"},{"date":"2025-12-31","value":"3.60","vol":"2.56"},{"date":"2025-09-30","value":"2.65","vol":"1.94"},{"date":"2025-06-30","value":"1.78","vol":"1.30"},{"date":"2025-03-31","value":"0.90","vol":"0.66"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.91 | 3.60 | 2.65 | 1.78 | 0.90 |
| 行业(次) | 0.64 | 2.56 | 1.94 | 1.30 | 0.66 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2026-03-31","value":"4.60","vol":"-2.75"},{"date":"2025-12-31","value":"14.32","vol":"16.48"},{"date":"2025-09-30","value":"13.57","vol":"4.59"},{"date":"2025-06-30","value":"20.17","vol":"2.93"},{"date":"2025-03-31","value":"-5.49","vol":"-26.34"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 4.60 | 14.32 | 13.57 | 20.17 | -5.49 |
| 行业 | -2.75 | 16.48 | 4.59 | 2.93 | -26.34 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.70","vol":"1.60"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.74","vol":"1.72"},{"date":"2025-03-31","value":"","vol":"0.00"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.70 | - | 0.74 | - |
| 行业 | 0.00 | 1.60 | 0.00 | 1.72 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 10/216 ， 60/216。
[{"date":"2026-03-31","value":"1.92","vol":"3.58"},{"date":"2025-12-31","value":"1.83","vol":"3.33"},{"date":"2025-09-30","value":"1.69","vol":"3.50"},{"date":"2025-06-30","value":"1.54","vol":"3.68"},{"date":"2025-03-31","value":"1.49","vol":"3.58"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
1.92 | 1.83 | 1.69 | 1.54 | 1.49 |
| 行业 | 3.58 | 3.33 | 3.50 | 3.68 | 3.58 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"1.57","vol":"2.94"},{"date":"2025-12-31","value":"1.49","vol":"2.71"},{"date":"2025-09-30","value":"1.34","vol":"2.75"},{"date":"2025-06-30","value":"1.24","vol":"2.90"},{"date":"2025-03-31","value":"1.19","vol":"2.81"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
1.57 | 1.49 | 1.34 | 1.24 | 1.19 |
| 行业 | 2.94 | 2.71 | 2.75 | 2.90 | 2.81 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 37/216 ， 48/216。
[{"date":"2026-03-31","value":"39.68","vol":"33.40"},{"date":"2025-12-31","value":"40.11","vol":"34.57"},{"date":"2025-09-30","value":"40.53","vol":"34.00"},{"date":"2025-06-30","value":"43.00","vol":"34.11"},{"date":"2025-03-31","value":"42.59","vol":"34.06"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
39.68 | 40.11 | 40.53 | 43.00 | 42.59 |
| 行业(%) | 33.40 | 34.57 | 34.00 | 34.11 | 34.06 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.77","vol":"9.83"},{"date":"2025-12-31","value":"0.78","vol":"1.77"},{"date":"2025-09-30","value":"0.79","vol":"1.19"},{"date":"2025-06-30","value":"0.88","vol":"0.88"},{"date":"2025-03-31","value":"0.87","vol":"1.44"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.77 | 0.78 | 0.79 | 0.88 | 0.87 |
| 行业(%) | 9.83 | 1.77 | 1.19 | 0.88 | 1.44 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2026年的收益，请投资者后续关注。
[{"date":"2022","yellowRectValue":"24.84","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"21.34","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"13.30","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"18.55","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]